Skip to main content

NewEdge Advisors, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1633516 NEW ORLEANS, LA

Position in NBIX

as of Mar 31, 2026 · filed Jun 3, 2026
Position Value
$1,721,314
-$122,192 QoQ
Shares Held
13,066
+0.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 1.6990662788917803.ToString("F0")% Shared 0.ToString("F0")% None 98.30093372110822.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

NewEdge Advisors, LLC holds $12,857,221 across 26 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (13.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
13,066 $1,721,314

All Filings in NBIX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,721,314 13,066
2025-12-31 $1,843,506 12,998
2025-09-30 $1,730,323 12,326
2025-06-30 $1,347,773 10,723
2025-03-31 $843,878 7,630
2024-12-31 $666,529 4,883
2024-09-30 $582,091 5,052
2024-06-30 $425,813 3,093
2024-03-31 $397,209 2,880
2023-12-31 $59,555 452
2023-09-30 $5,400 48
2023-06-30 $4,526 48
2023-03-31 $46,662 461
2022-12-31 $1,664,396 13,935